Retraction notice to "miR-33b in human cancer: Mechanistic and clinical perspectives" [Biomedicine & Pharmacotherapy 161 (2023) 114432] - 21/05/26
Doi : 10.1016/j.biopha.2026.119373
Wenlong Zhang a, b, Bincan Jiang c, Hecheng Zhu d, Ailan Cheng c, Can Li a, b, Haoxuan Huang a, b, Xuewen Li d, Yirui Kuang a, b, ⁎
a Department of Neurosurgery, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China
b Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan Province, 410008, China
c Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, 421001, China
d Changsha Kexin Cancer Hospital, Changsha, Hunan Province 410205, China
⁎ Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 199
Article 119373- juin 2026 Retour au numéro
Article précédent
- Retraction notice to "Effect of nano silver on gastroprotective activity against ethanol-induced stomach ulcer in rats" [Biomedicine & Pharmacotherapy 154 (2022) 113550]
- Ibrahim Abdel Aziz Ibrahim, Abbas I. Hussein, Mahmoud S. Muter, Abdulalah T. Mohammed, Morteta H. Al-Medhtiy, Suhayla Hamad Shareef, Peshawa Yunis Aziz, Nabaz Fisal Shakir Agha, Mahmood Ameen Abdulla
- Retraction notice to "4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive" [Biomedicine & Pharmacotherapy 118 (2019) 108589]
- Xu De Wang, Yuan Yuan Sun, Fan Zhi Qu, Guang Yue Su, Yu Qing Zhao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?